RNA
Atrium Therapeutics, Inc. Common Stock · Health Care · NASDAQ
$13.65
▲ $0.35 (+2.63%)
Market cap
$216.6M
52-week range
$11.40 – $73.06
Volume
221K
Previous close
$13.30
Atrium Therapeutics, Inc. Common Stock (RNA) is held by 2 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: Pentwater Capital Management LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Pentwater Capital Management LP Pentwater Capital Management LP |
0.0% | 603K | $8M | NEW (+603K) | $13.37 | 2026-03-31 |
| Sessa Capital IM, L.P. Sessa Capital IM, L.P. |
0.1% | 551K | $7M | NEW (+551K) | $13.37 | 2026-03-31 |
FAQ ▾
Which hedge funds hold RNA?
Tracked holders include: Pentwater Capital Management LP, Sessa Capital IM, L.P..
How much smart money owns RNA?
2 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading RNA?
No tracked Congressional trades in RNA on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.